Allucent Awarded BARDA Contract
to Support Acceleration of Next-Generation COVID-19 Booster Vaccines
At Allucent, we share your dedication to delivering novel therapies to patients with unmet needs. Designed to serve smaller companies, our organization offers capabilities and expertise that mirror those of larger CROs but delivered with a more personal and flexible style tailored for you. You will always partner with our best experts and gain insights through our consultative, problem-solving approach. Working together, we stay close to the science that drives therapeutic innovation.
Allucent focuses on supporting breakthrough science from small and mid-sized biotechs because you address the most complex and challenging disease states. Our deep experience and proven expertise in these multifaceted therapeutic areas strengthen your team as you move toward the goal of bringing new hope to patients through the clinical process. Our experts are eager to share their specialized knowledge and partner with you to advance your therapy.
Allucent is focused on serving the needs of small and mid-sized biotechs, and your project will receive the full attention of our top experts – our A-team. Experience in clinical research and regulatory matters permeates our organization. Our employees apply their expertise with a true commitment to working closely with you in developing treatments for patients who need them. Our organizational ethos is devoted to upholding attributes that are fundamental to achieving these goals.
Want to help small and mid-sized biotech companies change the therapeutic landscape?